Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-25 @ 2:51 AM
NCT ID:
NCT04042233
Eligibility Criteria:
Inclusion Criteria:
* Patient is undergoing a primary total hip arthroplasty
* Patient gives informed consent to participate in the study.
* Age Range \>18
Exclusion Criteria:
* Previous surgery on the hip (including hip scopes)
* BMI above 35
* Contraindication to receiving vancomycin or cefepime (allergy, medical issue, etc)
* Inability to locate the greater trochanter or administer the IO infusion
* Refusal to participate
* Diabetes
* Immunocompromised or immunosuppressed patients (HIV, Hep C, End stage renal disease, dialysis, transplant, chemo/radiation treatment in last 6 months, medications).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT04042233
Study Brief:
Protocol Section:
NCT04042233